These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25821641)

  • 21. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease.
    Perdigão C; Barata MA; Araújo MN; Mirfakhar FS; Castanheira J; Guimas Almeida C
    Front Cell Neurosci; 2020; 14():72. PubMed ID: 32362813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related Synapse Dysfunction in Early Alzheimer's Disease.
    Liu C
    Front Neurosci; 2022; 16():927256. PubMed ID: 35801178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease.
    Rodriguez-Perdigon M; Tordera RM; Gil-Bea FJ; Gerenu G; Ramirez MJ; Solas M
    Hippocampus; 2016 Oct; 26(10):1303-12. PubMed ID: 27258819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice.
    Sompol P; Furman JL; Pleiss MM; Kraner SD; Artiushin IA; Batten SR; Quintero JE; Simmerman LA; Beckett TL; Lovell MA; Murphy MP; Gerhardt GA; Norris CM
    J Neurosci; 2017 Jun; 37(25):6132-6148. PubMed ID: 28559377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Dual Role of Glutamatergic Neurotransmission in Alzheimer's Disease: From Pathophysiology to Pharmacotherapy.
    Bukke VN; Archana M; Villani R; Romano AD; Wawrzyniak A; Balawender K; Orkisz S; Beggiato S; Serviddio G; Cassano T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors.
    Kocahan S; Doğan Z
    Clin Psychopharmacol Neurosci; 2017 Feb; 15(1):1-8. PubMed ID: 28138104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β1-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse.
    Varga E; Juhász G; Bozsó Z; Penke B; Fülöp L; Szegedi V
    J Alzheimers Dis; 2015; 45(2):449-56. PubMed ID: 25547631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
    Huang S; Tong H; Lei M; Zhou M; Guo W; Li G; Tang X; Li Z; Mo M; Zhang X; Chen X; Cen L; Wei L; Xiao Y; Li K; Huang Q; Yang X; Liu W; Zhang L; Qu S; Li S; Xu P
    Brain Res; 2018 Jan; 1678():129-137. PubMed ID: 29066369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.
    Hynd MR; Scott HL; Dodd PR
    Neurochem Int; 2004 Oct; 45(5):583-95. PubMed ID: 15234100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.
    Tackenberg C; Brandt R
    J Neurosci; 2009 Nov; 29(46):14439-50. PubMed ID: 19923278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.
    Shankar GM; Bloodgood BL; Townsend M; Walsh DM; Selkoe DJ; Sabatini BL
    J Neurosci; 2007 Mar; 27(11):2866-75. PubMed ID: 17360908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.
    Li S; Stern AM
    Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.